List of Tables
Table 1. Peripheral Vasodilator Drugs Market Trends
Table 2. Peripheral Vasodilator Drugs Market Drivers & Opportunity
Table 3. Peripheral Vasodilator Drugs Market Challenges
Table 4. Peripheral Vasodilator Drugs Market Restraints
Table 5. Global Peripheral Vasodilator Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Peripheral Vasodilator Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Peripheral Vasodilator Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Peripheral Vasodilator Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Peripheral Vasodilator Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Peripheral Vasodilator Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Peripheral Vasodilator Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Peripheral Vasodilator Drugs
Table 13. Global Peripheral Vasodilator Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Vasodilator Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Peripheral Vasodilator Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Peripheral Vasodilator Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Peripheral Vasodilator Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Peripheral Vasodilator Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Peripheral Vasodilator Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Peripheral Vasodilator Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Peripheral Vasodilator Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Peripheral Vasodilator Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Peripheral Vasodilator Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Peripheral Vasodilator Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Peripheral Vasodilator Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Peripheral Vasodilator Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Peripheral Vasodilator Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Peripheral Vasodilator Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Peripheral Vasodilator Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Peripheral Vasodilator Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Peripheral Vasodilator Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Peripheral Vasodilator Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Peripheral Vasodilator Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Peripheral Vasodilator Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Peripheral Vasodilator Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Peripheral Vasodilator Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Peripheral Vasodilator Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Peripheral Vasodilator Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Peripheral Vasodilator Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Peripheral Vasodilator Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Peripheral Vasodilator Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Peripheral Vasodilator Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Peripheral Vasodilator Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Peripheral Vasodilator Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Peripheral Vasodilator Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Peripheral Vasodilator Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Peripheral Vasodilator Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Peripheral Vasodilator Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Peripheral Vasodilator Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer, Inc. Company Information
Table 58. Pfizer, Inc. Introduction and Business Overview
Table 59. Pfizer, Inc. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer, Inc. Peripheral Vasodilator Drugs Product Offerings
Table 61. Pfizer, Inc. Recent Development
Table 62. Novartis AG Company Information
Table 63. Novartis AG Introduction and Business Overview
Table 64. Novartis AG Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Novartis AG Peripheral Vasodilator Drugs Product Offerings
Table 66. Novartis AG Recent Development
Table 67. GSK plc Company Information
Table 68. GSK plc Introduction and Business Overview
Table 69. GSK plc Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. GSK plc Peripheral Vasodilator Drugs Product Offerings
Table 71. GSK plc Recent Development
Table 72. AstraZeneca Company Information
Table 73. AstraZeneca Introduction and Business Overview
Table 74. AstraZeneca Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. AstraZeneca Peripheral Vasodilator Drugs Product Offerings
Table 76. AstraZeneca Recent Development
Table 77. Merck & Co., Inc. Company Information
Table 78. Merck & Co., Inc. Introduction and Business Overview
Table 79. Merck & Co., Inc. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Merck & Co., Inc. Peripheral Vasodilator Drugs Product Offerings
Table 81. Merck & Co., Inc. Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Introduction and Business Overview
Table 84. Sanofi Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sanofi Peripheral Vasodilator Drugs Product Offerings
Table 86. Sanofi Recent Development
Table 87. Bayer AG Company Information
Table 88. Bayer AG Introduction and Business Overview
Table 89. Bayer AG Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Bayer AG Peripheral Vasodilator Drugs Product Offerings
Table 91. Bayer AG Recent Development
Table 92. Abbott Laboratories Company Information
Table 93. Abbott Laboratories Introduction and Business Overview
Table 94. Abbott Laboratories Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Abbott Laboratories Peripheral Vasodilator Drugs Product Offerings
Table 96. Abbott Laboratories Recent Development
Table 97. Bristol-Myers Squibb Company Company Information
Table 98. Bristol-Myers Squibb Company Introduction and Business Overview
Table 99. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Product Offerings
Table 101. Bristol-Myers Squibb Company Recent Development
Table 102. Boehringer Ingelheim International GmbH Company Information
Table 103. Boehringer Ingelheim International GmbH Introduction and Business Overview
Table 104. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Product Offerings
Table 106. Boehringer Ingelheim International GmbH Recent Development
Table 107. Teva Pharmaceutical Industries Ltd. Company Information
Table 108. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 109. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Offerings
Table 111. Teva Pharmaceutical Industries Ltd. Recent Development
Table 112. Viatris, Inc. Company Information
Table 113. Viatris, Inc. Introduction and Business Overview
Table 114. Viatris, Inc. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Viatris, Inc. Peripheral Vasodilator Drugs Product Offerings
Table 116. Viatris, Inc. Recent Development
Table 117. Sun Pharmaceutical Industries Ltd. Company Information
Table 118. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 119. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Product Offerings
Table 121. Sun Pharmaceutical Industries Ltd. Recent Development
Table 122. Lupin Company Information
Table 123. Lupin Introduction and Business Overview
Table 124. Lupin Peripheral Vasodilator Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Lupin Peripheral Vasodilator Drugs Product Offerings
Table 126. Lupin Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Peripheral Vasodilator Drugs Downstream Customers
Table 130. Peripheral Vasodilator Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Peripheral Vasodilator Drugs Product Picture
Figure 2. Global Peripheral Vasodilator Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peripheral Vasodilator Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Peripheral Vasodilator Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Peripheral Vasodilator Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Peripheral Vasodilator Drugs Report Years Considered
Figure 7. Global Peripheral Vasodilator Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Peripheral Vasodilator Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Peripheral Vasodilator Drugs Revenue in 2023
Figure 10. Peripheral Vasodilator Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Calcium Channel Blockers Picture
Figure 12. Alpha-adrenergic Blockers Picture
Figure 13. Potassium Channel Activators Picture
Figure 14. Others Picture
Figure 15. Global Peripheral Vasodilator Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Peripheral Vasodilator Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Peripheral Vasodilator Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Peripheral Vasodilator Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Peripheral Vasodilator Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Retail Pharmacies
Figure 22. Product Picture of Others
Figure 23. Global Peripheral Vasodilator Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Peripheral Vasodilator Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Peripheral Vasodilator Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Peripheral Vasodilator Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Peripheral Vasodilator Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Peripheral Vasodilator Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Peripheral Vasodilator Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Peripheral Vasodilator Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Peripheral Vasodilator Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Peripheral Vasodilator Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Peripheral Vasodilator Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Peripheral Vasodilator Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Peripheral Vasodilator Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Peripheral Vasodilator Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Peripheral Vasodilator Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Peripheral Vasodilator Drugs Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Peripheral Vasodilator Drugs Sales Volume (%), (2019-2030)
Figure 40. United States Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. China Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. China Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. India Peripheral Vasodilator Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Peripheral Vasodilator Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. India Peripheral Vasodilator Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. Peripheral Vasodilator Drugs Industrial Chain
Figure 62. Peripheral Vasodilator Drugs Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
